175 related articles for article (PubMed ID: 38529533)
1. Morphometric similarity differences in drug-naive Parkinson's disease correlate with transcriptomic signatures.
Wang Y; Xiao Y; Xing Y; Yu M; Wang X; Ren J; Liu W; Zhong Y
CNS Neurosci Ther; 2024 Mar; 30(3):e14680. PubMed ID: 38529533
[TBL] [Abstract][Full Text] [Related]
2. Age-associated cortical similarity networks correlate with cell type-specific transcriptional signatures.
Niu J; Jiao Q; Cui D; Dou R; Guo Y; Yu G; Zhang X; Sun F; Qiu J; Dong L; Cao W
Cereb Cortex; 2024 Jan; 34(1):. PubMed ID: 38037843
[TBL] [Abstract][Full Text] [Related]
3. Cortical morphometric vulnerability to generalised epilepsy reflects chromosome- and cell type-specific transcriptomic signatures.
Li J; Keller SS; Seidlitz J; Chen H; Li B; Weng Y; Meng Y; Yang S; Xu Q; Zhang Q; Yang F; Lu G; Bernhardt BC; Zhang Z; Liao W
Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12857. PubMed ID: 36278258
[TBL] [Abstract][Full Text] [Related]
4. Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson's disease.
Thomas GEC; Zarkali A; Ryten M; Shmueli K; Gil-Martinez AL; Leyland LA; McColgan P; Acosta-Cabronero J; Lees AJ; Weil RS
Brain; 2021 Jul; 144(6):1787-1798. PubMed ID: 33704443
[TBL] [Abstract][Full Text] [Related]
5. Network connectivity and local transcriptomic vulnerability underpin cortical atrophy progression in Parkinson's disease.
Vo A; Tremblay C; Rahayel S; Shafiei G; Hansen JY; Yau Y; Misic B; Dagher A
Neuroimage Clin; 2023; 40():103523. PubMed ID: 38016407
[TBL] [Abstract][Full Text] [Related]
6. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
7. Cortical thinning across Parkinson's disease stages and clinical correlates.
Wilson H; Niccolini F; Pellicano C; Politis M
J Neurol Sci; 2019 Mar; 398():31-38. PubMed ID: 30682518
[TBL] [Abstract][Full Text] [Related]
8. Differences in network controllability and regional gene expression underlie hallucinations in Parkinson's disease.
Zarkali A; McColgan P; Ryten M; Reynolds R; Leyland LA; Lees AJ; Rees G; Weil RS
Brain; 2020 Dec; 143(11):3435-3448. PubMed ID: 33118028
[TBL] [Abstract][Full Text] [Related]
9. Functional Connectomics and Disease Progression in Drug-Naïve Parkinson's Disease Patients.
De Micco R; Agosta F; Basaia S; Siciliano M; Cividini C; Tedeschi G; Filippi M; Tessitore A
Mov Disord; 2021 Jul; 36(7):1603-1616. PubMed ID: 33639029
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomic Signatures Associated With Regional Cortical Thickness Changes in Parkinson's Disease.
Keo A; Dzyubachyk O; van der Grond J; van Hilten JJ; Reinders MJT; Mahfouz A
Front Neurosci; 2021; 15():733501. PubMed ID: 34658772
[TBL] [Abstract][Full Text] [Related]
11. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
[TBL] [Abstract][Full Text] [Related]
12. Altered functional network topology correlates with clinical measures in very early-stage, drug-naïve Parkinson's disease.
Sreenivasan K; Mishra V; Bird C; Zhuang X; Yang Z; Cordes D; Walsh RR
Parkinsonism Relat Disord; 2019 May; 62():3-9. PubMed ID: 30772280
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional patterns of the cortical Morphometric Inverse Divergence in first-episode, treatment-naïve early-onset schizophrenia.
Yao G; Luo J; Zou T; Li J; Hu S; Yang L; Li X; Tian Y; Zhang Y; Feng K; Xu Y; Liu P
Neuroimage; 2024 Jan; 285():120493. PubMed ID: 38086496
[TBL] [Abstract][Full Text] [Related]
14. Primary disruption of the default mode network subsystems in drug-naïve Parkinson's disease with mild cognitive impairments.
Hou Y; Yuan X; Wei Q; Ou R; Yang J; Gong Q; Shang H
Neuroradiology; 2020 Jun; 62(6):685-692. PubMed ID: 32064569
[TBL] [Abstract][Full Text] [Related]
15. Regional changes of brain structure during progression of idiopathic Parkinson's disease - A longitudinal study using deformation based morphometry.
Pieperhoff P; Südmeyer M; Dinkelbach L; Hartmann CJ; Ferrea S; Moldovan AS; Minnerop M; Diaz-Pier S; Schnitzler A; Amunts K
Cortex; 2022 Jun; 151():188-210. PubMed ID: 35439717
[TBL] [Abstract][Full Text] [Related]
16. Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration.
Hanganu A; Bedetti C; Jubault T; Gagnon JF; Mejia-Constain B; Degroot C; Lafontaine AL; Chouinard S; Monchi O
Mov Disord; 2013 Sep; 28(10):1360-9. PubMed ID: 23801590
[TBL] [Abstract][Full Text] [Related]
17. Diffusion and structural MRI as potential biomarkers in people with Parkinson's disease and cognitive impairment.
Huang CC; Chen PH; Tsai CC; Chiang HF; Hsieh CC; Chen TL; Liao WH; Chen YL; Wang JJ
Eur Radiol; 2024 Jan; 34(1):126-135. PubMed ID: 37572194
[TBL] [Abstract][Full Text] [Related]
18. Regional expression of genes mediating trans-synaptic alpha-synuclein transfer predicts regional atrophy in Parkinson disease.
Freeze B; Acosta D; Pandya S; Zhao Y; Raj A
Neuroimage Clin; 2018; 18():456-466. PubMed ID: 29868450
[TBL] [Abstract][Full Text] [Related]
19. Morphometric magnetic resonance imaging cortico-subcortical features in Parkinson's disease with mild cognitive impairment.
Cicero CE; Donzuso G; Luca A; Davì M; Baschi R; Mostile G; Giuliano L; Palmucci S; Salerno A; Monastero R; Nicoletti A; Zappia M
Eur J Neurol; 2022 Nov; 29(11):3197-3204. PubMed ID: 35790057
[TBL] [Abstract][Full Text] [Related]
20. Connectivity Correlates of Anxiety Symptoms in Drug-Naive Parkinson's Disease Patients.
De Micco R; Satolli S; Siciliano M; Di Nardo F; Caiazzo G; Russo A; Giordano A; Esposito F; Tedeschi G; Tessitore A
Mov Disord; 2021 Jan; 36(1):96-105. PubMed ID: 33169858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
